Global paediatric, orthopaedic experts to offer treatment, consultation in Abu Dhabi this month
SAMIHAH ZAMAN (ALETIHAD)A trio of global experts in paediatrics and a top orthopaedic surgeon are offering care and consultations in Abu Dhabi this month, the Department of Health – Abu Dhabi (DoH) has announced.The doctors are headed to the emirate as part of the DoH's Visiting Physicians Programme, which aims to extend advanced healthcare services to residents.'The Department of Health – Abu Dhabi welcomes top-tier doctors from around the world to the Emirate during June, offering exceptional healthcare services through the Visiting Physicians Programme,' the DoH - Abu Dhabi's health regulator - announced in a post on its social media platforms.
Visiting Physicians: June (From left to right) Dr. Kaveh Asadi, Dr. Matthew Dobbs, and Professor Oliver Berborgt are offering care in Abu Dhabi this June
Dr. Kaveh Asadi, paediatric neurosurgery consultant at St Mary Hospital, Paley Institute in Florida, US, is one of the eminent doctors who will see patients in Abu Dhabi. He will be available at Burjeel Medical City's Paley Middle East Centre between June 9-13, and also on June 23. Dr. Asadi specialises in selective dorsal rhizotomy for the treatment of cerebral palsy, intra dural tumour treatment, craniofacial surgery, and tethered cord releases.Dr. Matthew Dobbs, paediatric orthopaedic consultant at St. Mary Hospital in the US, will also join Dr. Asadi at the Burjeel Medical City between June 9-13. Dr. Dobbs' areas of specialisation include the treatment of congenital and developmental foot, lower extremity deformities, flatfoot deformities, cerebral palsy spasticity, and clubfoot.Professor Oliver Verborgt, head of services for orthopaedics at Belgium's Monica Hospital, will also offer his expert care at the Tarmeem Hospital in Abu Dhabi on June 27 and 28. Prof Verborgt specialises in shoulder and elbow surgeries and reconstruction, and in the management of sports-related injuries.The DoH has urged patients to directly contact the respective hospitals to book appointments.
Earlier this month, Dr. Annique Hogan, an award-winning physician and paediatrician at Children's Hospital of Philadelphia, also saw patients at Sheikh Khalifa Medical City, sharing her expert advice on the care of children with complex medical needs.
Complex Care Close to Home The DoH's Visiting Physicians Programme breaks new ground every month, ensuring care for complex medical conditions within Abu Dhabi. Since its launch in 2021, the programme has partnered with leading global health institutions to offer treatment and surgeries for patients in the region while eliminating the need for them to travel abroad.As of December 2024, a total of 3,277 patients with rare and complex medical conditions had received care in Abu Dhabi as part of the programme.According to the DoH, the top five specialties in which visiting physicians offer care include paediatric haematology for bone marrow transplants; plastic surgery for lymphedema and brachial plexus; adult orthopaedic surgeries for complex ankle, foot, shoulder, hand and scoliosis; paediatric orthopaedic care for limb lengthening and limb deformities; and ophthalmology.
The programme has also allowed for knowledge transfer, the enhancement of local healthcare expertise and post-surgical rehabilitation care, and the improvement of health outcomes throughout Abu Dhabi.
Source: Aletihad - Abu Dhabi
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
19 minutes ago
- Zawya
UAE: 'Malaffi' reaches 3.5bln clinical records
Malaffi, the region's first Health Information Exchange (HIE) platform and a strategic initiative of the Department of Health – Abu Dhabi (DoH), operated by M42's Abu Dhabi Health Data Services (ADHDS), has reached 3.5 billion clinical records, representing 12.7 million patient profiles across Abu Dhabi to help progress the UAE's advance in precision and preventive care. The milestone highlights Malaffi's ongoing evolution as a cutting-edge Health Information Exchange platform that supports innovation and excellence in the delivery of healthcare services. With connections to nearly all healthcare facilities – including hospitals, clinics and pharmacies - in the Emirate, Malaffi now supports 53,476 authorised users, from doctors and nurses to allied health professionals across 3,072 healthcare facilities in Abu Dhabi. The platform's latest enhancements expand its capabilities with the addition of over 160,000 M42 Pharmacogenomics Reports, offering personalised insights into patients' genetic responses to medications to optimise treatment plans. Furthermore, new diagnostic test results across key specialities, such as Mental Health, Ophthalmology, Otolaryngology, and Respiratory Diagnostics, provide clinicians with deeper insights to elevate patient care. These advancements are complemented by features like the Radiology Image Exchange, allowing access to radiology images from over 60 facilities to all authorised clinical users, and the AI-powered Patient Risk Profile, which predicts risks for chronic conditions and acute events. Together, these innovations streamline workflows, enhance decision-making and support better healthcare outcomes. Dr. Noura Khamis Al Ghaithi, Undersecretary of the DoH, said, 'Malaffi's access to 3.5 billion medical records marks a pivotal milestone, reflecting the DoH's steadfast commitment to creating the world's most intelligent, patient-centric healthcare system. By harnessing innovative healthcare solutions powered by artificial intelligence, such as pharmacogenomics and predictive analytics, Malaffi continues to advance, enabling healthcare providers to deliver services that meet the highest standards of care and empower community members to lead healthier lives.' Kareem Shaheen, CEO of M42's Digital Health Solutions platform, stated, 'This milestone is a testament to the collaborative efforts of Abu Dhabi's healthcare ecosystem and the visionary leadership of the DoH. Aligned with M42's mission to advance innovation in health for people, Malaffi is securely connecting critical patient information with clinicians to enable informed decision-making, elevate healthcare standards and deliver quality patient outcomes.' With 3.5 billion clinical records now connected, Malaffi plays a key role in enhancing Abu Dhabi's healthcare ecosystem and providing a strong foundation for research, from AI-driven analytics to advanced treatments.
Al Etihad
9 hours ago
- Al Etihad
Abu Dhabi: Malaffi reaches 3.5 billion clinical records
14 Aug 2025 11:36 ABU DHABI (ALETIHAD) Malaffi, the region's first Health Information Exchange (HIE) platform and a strategic initiative of the Department of Health – Abu Dhabi (DoH), operated by M42's Abu Dhabi Health Data Services (ADHDS), has achieved a significant milestone by reaching 3.5 billion clinical records, representing 12.7 million unique patient profiles across Abu Dhabi to help progress the UAE's advance in precision and preventive care. The milestone highlights Malaffi's ongoing evolution as a cutting-edge Health Information Exchange platform that supports innovation and excellence in the delivery of healthcare services. Malaffi continues to improve healthcare professionals' access to and utilisation of critical patient information. With connections to nearly all healthcare facilities – including hospitals, clinics and pharmacies - in the Emirate, Malaffi now supports 53,476 authorised users, from doctors and nurses to allied health professionals across 3,072 healthcare facilities in Abu platform's latest enhancements expand its capabilities with the addition of over 160,000 M42 Pharmacogenomics Reports, offering personalised insights into patients' genetic responses to medications to optimise treatment plans. Furthermore, new diagnostic test results across key specialities—such as Mental Health, Ophthalmology, Otolaryngology, and Respiratory Diagnostics—provide clinicians with deeper insights to elevate patient advancements are complemented by features like the Radiology Image Exchange, allowing access to radiology images from over 60 facilities to all authorised clinical users, and the AI-powered Patient Risk Profile, which predicts risks for chronic conditions and acute events. Together, these innovations streamline workflows, enhance decision-making and support better healthcare Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi (DoH), said: 'Malaffi's access to 3.5 billion medical records marks a pivotal milestone, reflecting the Department of Health – Abu Dhabi's steadfast commitment to creating the world's most intelligent, patient-centric healthcare system." She added: "By harnessing innovative healthcare solutions powered by artificial intelligence, such as pharmacogenomics and predictive analytics, Malaffi continues to advance, enabling healthcare providers to deliver services that meet the highest standards of care and empower community members to lead healthier lives. This achievement further strengthens Abu Dhabi's position as a globally leading digital healthcare ecosystem.'Kareem Shaheen, CEO of M42's Digital Health Solutions platform, added: "This milestone is a testament to the collaborative efforts of Abu Dhabi's healthcare ecosystem and the visionary leadership of the Department of Health." He added: "Aligned with M42's mission to advance innovation in health for people, Malaffi is securely connecting critical patient information with clinicians to enable informed decision-making, elevate healthcare standards and deliver quality patient outcomes. With every new feature and service we introduce, we are revolutionising the way care is delivered, ensuring better outcomes for patients and providers alike." With 3.5 billion clinical records now connected, Malaffi plays a key role in enhancing Abu Dhabi's healthcare ecosystem and providing a strong foundation for research, from AI-driven analytics to advanced treatments. As Abu Dhabi progresses in its digital transformation, Malaffi supports the Emirate's growth by offering innovative solutions that benefit patients and providers, reinforcing its position as a global hub for healthcare innovation. Source: Aletihad - Abu Dhabi
Gulf Today
a day ago
- Gulf Today
Aunt's heroic donation saves nephew as UAE doctors perform youngest infant liver transplant
A five-month old 4.4-kilogramme Emirati boy, stricken with a rare unpreventable recessive X disorder, and the youngest recipient of a donated liver in the UAE, courtesy of his 37-year-old paternal aunt, shall now be on lifelong monitoring and treatment. Fifth child Ahmed Al Yassi is recuperating at the Burjeel Medical City-Paediatric Intensive Care Unit (BMC-PICU) since his April 4, 2025 12-hour ultra-delicate transplantation. His giant strength, and his family's and the medical team's indefatigability, serve as an inspiring testimony for the August 13 'World Organ Donation Day." The WODD 2025 theme is 'Answering the Call,' for the continuous correct information dissemination on the necessity to grant one's organ/s to save lives. In the UAE, since 2017, is the Ministry of Health and Prevention-spearheaded National Programme for Donation and Transplantation of Human Organs and Tissues-Hayat Programme. According to a press statement, quoting undersecretary, Dr. Mohammed Salim Al Olama, it has been boosted with advanced digital solutions and artificial intelligence that guarantees transparency and efficiency at every stage of organ donation and transplantation process. Its website as of 4:30 p.m. of August 13 had '37,298 registered donors.' From a press statement quoting Department of Health-Abu Dhabi undersecretary Dr. Noura Khamis Al Ghaithi, 1,380 transplantations, through the Hayat Programme, were carried out from 2017 to 2024. The 2024 were at 290: seven heart, 142 kidney, 117 liver, 22 lung, and two pancreas. Over at BMC, elated was Ahmed's father Yahya: 'My baby's recovery is nothing short of a miracle. We were once a family living in fear of losing another child due to a liver problem. I hope our story inspires others to come forward, to learn more, and consider becoming donors. You never know whose life might change.' Abdominal Transplant and Hepato-Pancreatic Biliary surgeon Dr. Johns Shaji Mathew confirmed that Ahmed shall receive 'lifetime monitoring and therapy that includes immunosuppressive medications to prevent organ rejection, while the transplant on Ahmed has resolved the liver-related complications.' 'Ahmed will be regularly supervised by liver and genetics specialists for ongoing evaluation,' added Mathew, among the multi-disciplinary team members, led by Burjeel Abdominal Multi-Organ Transplant Programme-Transplant Surgery director Dr. Gourab Sen. The other on-case Transplant Team were Anaesthesia Division chairperson Dr. Ramamurthy Baskaran and specialists Dr. George Jacob and Dr. Anshu S., and Paediatric Intensive Care Unit (PICU) consultant Dr. Kesava Ramakrishnan. Their advice: 'urgent transplantation.' Ahmed's health debilitated due to the rise of his liver enzymes immediately birth. His diagnostics demonstrated that he is afflicted with ATP6AP1-Congenital Disorder of Glycosylation (ATP6AP1-CDG). Instrumental were the 'family's conviction' and the bravery-cum-volunteerism of mother-of-five Haifaa, Yahya's sister-in-law, who passed all compatibility tests. She and Ahmed are A+ blood type. Mathew said: 'The family's conviction came from the fact that without a transplant, Ahmed's survival chances were extremely low. They already experienced the loss of an older son to similar complications, which made them determined not to lose another.' 'The doctors gave us new hope. My sister-in-law gave us life again,' said Yahya. The USA-headquartered public-private-supported Frontiers in Congenital Disorders of Glycosylation (FCDG) portal notes that ATP6AP1-CDG generally affects males at one every one million. Ahmed has so far become the 31st survivor. There are 30 in other countries. The oldest patient is age 67. ATP6AP1-CDG 'age onset' range from the mother's pregnancy to age two, notes the Orphanet Knowledge on Rare Diseases and Orphan Drugs. From the FCDG, patients 'may have variable degree of liver dysfunction and immunodeficiency with recurrent infections.' Impaired-ness include developmental delays; abnormal body movement; gastrointestinal, urinary and genital problems; congenital heart defects and blood syndromes. So far, the solution is 'liver transplantation which has been successful in patients with severe liver failure.' Mathew said decreased transmission would only be via 'genetic screening and pre-marital genetic counselling to identify carriers and inform reproductive decisions for families with a known history.' Ahmed's family history has 'his grandfather passed on in 2010 due to a liver disease.' From the BMC Transplant Team that encourages a well-informed community on organ donation and transplantation: 'Ahmed's survival underscores the transformative power of organ donation and the advanced capabilities we now have in the UAE to perform complex, high-stakes surgeries for even the tiniest patients. Liver transplantation is not just surgical procedure; it is a second chance at life for those with no other options.'
